Cargando…
Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
BACKGROUND: Radical surgical resection is regarded as the best treatment for hepatic hilar cholangiocarcinoma. However, 60%-70% of patients have lost the chance of surgery at the time of diagnosis. Simple biliary stent or drainage tube placement may fail in a short time due to tumor invasion or over...
Autores principales: | Zheng, Wen-Heng, Yu, Tao, Luo, Ya-Hong, Wang, Ying, Liu, Ye-Fu, Hua, Xiang-Dong, Lin, Jie, Ma, Zuo-Hong, Ai, Fu-Lu, Wang, Tian-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580316/ https://www.ncbi.nlm.nih.gov/pubmed/31236199 http://dx.doi.org/10.4251/wjgo.v11.i6.489 |
Ejemplares similares
-
Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2017) -
Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020) -
Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer
por: Bian, Li-Fang, et al.
Publicado: (2020) -
Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2019) -
Perineural invasion of hilar cholangiocarcinoma in Chinese population: One center’s experience
por: Li, Cheng-Gang, et al.
Publicado: (2020)